| 參考文獻 |
[1] Bangham, A. D.; Horne, R. W., "Negative Staining of Phospholipids and Their
Structural Modification by Surface-Active Agents as Observed in the Electron
Microscope." J Mol Biol, 8, 1964, 660-8.
[2] Bangham, A. D.; Standish, M. M.; Weissmann, G., "The action of steroids and
streptolysin S on the permeability of phospholipid structures to cations." J Mol
Biol, 13 (1), 1965, 253-9.
[3] Sessa, G.; Weissmann, G., "Incorporation of Lysozyme into Liposomes - a Model
for Structure-Linked Latency." J Biol Chem, 245 (13), 1970, 3295-3301.
[4] Lasic, D. D., "Novel applications of liposomes." Trends Biotechnol, 16 (7), 1998,
307-21.
[5] Johnson, S. M., "The effect of charge and cholesterol on the size and thickness of
sonicated phospholipid vesicles." Biochim Biophys Acta, 307 (1), 1973, 27-41.
[6] Juliano, R. L.; Stamp, D., "The effect of particle size and charge on the clearance
rates of liposomes and liposome encapsulated drugs." Biochem Biophys Res
Commun, 63 (3), 1975, 651-8.
[7] Grull, H.; Langereis, S., "Hyperthermia-triggered drug delivery from temperature-
sensitive liposomes using MRI-guided high intensity focused ultrasound." J
Control Release, 161 (2), 2012, 317-327.
[8] Monteiro, N.; Martins, A.; Reis, R. L.; Neves, N. M., "Liposomes in tissue
engineering and regenerative medicine." J R Soc Interface, 11 (101), 2014,
20140459.
[9] Taylor, K. M. G.; Taylor, G.; Kellaway, I. W.; Stevens, J., "Drug Entrapment and
Release from Multilamellar and Reverse-Phase Evaporation Liposomes." Int J
Pharm, 58 (1), 1990, 49-55.
[10] Briuglia, M. L.; Rotella, C.; McFarlane, A.; Lamprou, D. A., "Influence of
cholesterol on liposome stability and on in vitro drug release." Drug Deliv Transl
Res, 5 (3), 2015, 231-42.
[11] Milla, P.; Dosio, F.; Cattel, L., "PEGylation of proteins and liposomes: a powerful
and flexible strategy to improve the drug delivery." Curr Drug Metab, 13 (1), 2012,
105-19.
[12] Gregoriadis, G., "Drug entrapment in liposomes." FEBS Lett, 36 (3), 1973, 292-6.
[13] Barenholz, Y., "Doxil (R) - The first FDA-approved nano-drug: Lessons learned." J
Control Release, 160 (2), 2012, 117-134.
[14] Matsumura, Y.; Maeda, H., "A New Concept for Macromolecular Therapeutics in
Cancer-Chemotherapy - Mechanism of Tumoritropic Accumulation of Proteins and
the Antitumor Agent Smancs." Cancer Res, 46 (12), 1986, 6387-6392.
[15] Fang, J.; Nakamura, H.; Maeda, H., "The EPR effect: Unique features of tumor
blood vessels for drug delivery, factors involved, and limitations and augmentation
of the effect." Adv Drug Deliver Rev, 63 (3), 2011, 136-151.
[16] Torchilin, V., "Tumor delivery of macromolecular drugs based on the EPR effect."
Adv Drug Deliver Rev, 63 (3), 2011, 131-135.
[17] Gregoriadis, G.; Wills, E. J.; Swain, C. P.; Tavill, A. S., "Drug-carrier potential of
liposomes in cancer chemotherapy." Lancet, 1 (7870), 1974, 1313-6.
[18] Patel, N. R.; Pattni, B. S.; Abouzeid, A. H.; Torchilin, V. P., "Nanopreparations to
overcome multidrug resistance in cancer." Adv Drug Deliver Rev, 65 (13-14), 2013,
1748-1762.
[19] Franco, M. S.; Gomes, E. R.; Roque, M. C.; Oliveira, M. C., "Triggered Drug
Release From Liposomes: Exploiting the Outer and Inner Tumor Environment."
Front Oncol, 11, 2021, 623760.
[20] Wang, Y. F.; Kohane, D. S., "External triggering and triggered targeting strategies
for drug delivery." Nat Rev Mater, 2 (6), 2017, 1-14.
[21] Mo, R.; Gu, Z., "Tumor microenvironment and intracellular signal-activated
nanomaterials for anticancer drug delivery." Mater Today, 19 (5), 2016, 274-283.
[22] Zhao, Y.; Ren, W.; Zhong, T.; Zhang, S.; Huang, D.; Guo, Y.; Yao, X.;
Wang, C.; Zhang, W. Q.; Zhang, X.; Zhang, Q., "Tumor-specific pH-responsive
peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing
glioma targeting and anti-tumor activity." J Control Release, 222, 2016, 56-66.
[23] Zhang, S. Y.; Zhao, Y., "Controlled Release from Cleavable Polymerized Liposomes
upon Redox and pH Stimulation." Bioconjugate Chem, 22 (4), 2011, 523-528.
[24] Loew, M.; Forsythe, J. C.; McCarley, R. L., "Lipid Nature and Their Influence on
Opening of Redox-Active Liposomes." Langmuir, 29 (22), 2013, 6615-6623.
[25] Mizukami, S.; Kashibe, M.; Matsumoto, K.; Hori, Y.; Kikuchi, K., "Enzyme-
triggered compound release using functionalized antimicrobial peptide derivatives."
Chemical Science, 8 (4), 2017, 3047-3053.
[26] Sarkar, N.; Banerjee, J.; Hanson, A. J.; Elegbede, A. I.; Rosendahl, T.;
Krueger, A. B.; Banerjee, A. L.; Tobwala, S.; Wang, R. Y.; Lu, X. N.; Mallik,
S.; Srivastava, D. K., "Matrix metalloproteinase-assisted triggered release of
liposomal contents." Bioconjugate Chem, 19 (1), 2008, 57-64.
[27] Pourhassan, H.; Clergeaud, G.; Hansen, A. E.; Ostrem, R. G.; Fliedner, F. P.; Melander, F.; Nielsen, O. L.; O′Sullivan, C. K.; Kjaer, A.; Andresen, T. L., "Revisiting the use of sPLA(2)-sensitive liposomes in cancer therapy." J Control Release, 261, 2017, 163-173.
[28] Ong, W.; Yang, Y.; Cruciano, A. C.; McCarley, R. L., "Redox-triggered contents
release from liposomes." J Am Chem Soc, 130 (44), 2008, 14739-44.
[29] Van Laer, K.; Hamilton, C. J.; Messens, J., "Low-molecular-weight thiols in thiol-
disulfide exchange." Antioxid Redox Signal, 18 (13), 2013, 1642-53.
[30] Wu, G.; Fang, Y. Z.; Yang, S.; Lupton, J. R.; Turner, N. D., "Glutathione
metabolism and its implications for health." J Nutr, 134 (3), 2004, 489-92.
[31] Owen, J. B.; Butterfield, D. A., "Measurement of oxidized/reduced glutathione
ratio." Methods Mol Biol, 648, 2010, 269-77.
[32] Bounous, G.; Batist, G.; Gold, P., "Immunoenhancing property of dietary whey
protein in mice: role of glutathione." Clin Invest Med, 12 (3), 1989, 154-61.
[33] Droge, W.; Schulze-Osthoff, K.; Mihm, S.; Galter, D.; Schenk, H.; Eck, H. P.;
Roth, S.; Gmunder, H., "Functions of glutathione and glutathione disulfide in
immunology and immunopathology." FASEB J, 8 (14), 1994, 1131-8.
[34] Delaunay-Moisan, A.; Ponsero, A.; Toledano, M. B., "Reexamining the Function
of Glutathione in Oxidative Protein Folding and Secretion." Antioxid Redox Signal,
27 (15), 2017, 1178-1199.
[35] Deponte, M., "The Incomplete Glutathione Puzzle: Just Guessing at Numbers and
Figures?" Antioxid Redox Signal, 27 (15), 2017, 1130-1161.
[36] Ottaviano, F. G.; Handy, D. E.; Loscalzo, J., "Redox regulation in the extracellular
environment." Circ J, 72 (1), 2008, 1-16.
[37] Forman, H. J.; Zhang, H.; Rinna, A., "Glutathione: overview of its protective roles,
measurement, and biosynthesis." Mol Aspects Med, 30 (1-2), 2009, 1-12.
[38] Bachhawat, A. K.; Kaur, A., "Glutathione Degradation." Antioxid Redox Signal, 27
(15), 2017, 1200-1216.
[39] Franco, R.; Cidlowski, J. A., "Apoptosis and glutathione: beyond an antioxidant."
Cell Death Differ, 16 (10), 2009, 1303-14.
[40] Circu, M. L.; Aw, T. Y., "Glutathione and modulation of cell apoptosis." Biochim
Biophys Acta, 1823 (10), 2012, 1767-77.
[41] Townsend, D. M.; Tew, K. D.; Tapiero, H., "The importance of glutathione in
human disease." Biomed Pharmacother, 57 (3-4), 2003, 145-55.
[42] Sian, J.; Dexter, D. T.; Lees, A. J.; Daniel, S.; Agid, Y.; Javoy-Agid, F.;
Jenner, P.; Marsden, C. D., "Alterations in glutathione levels in Parkinson′s disease
and other neurodegenerative disorders affecting basal ganglia." Ann Neurol, 36 (3),
1994, 348-55.
[43] Schulz, J. B.; Lindenau, J.; Seyfried, J.; Dichgans, J., "Glutathione, oxidative
stress and neurodegeneration." Eur J Biochem, 267 (16), 2000, 4904-11.
[44] Kameoka, M.; Okada, Y.; Tobiume, M.; Kimura, T.; Ikuta, K., "Intracellular
glutathione as a possible direct blocker of HIV type 1 reverse transcription." Aids
Res Hum Retrov, 12 (17), 1996, 1635-1638.
[45] Kelly, F. J., "Gluthathione: in defence of the lung." Food Chem Toxicol, 37 (9-10),
1999, 963-6.
[46] Biswas, S. K.; Rahman, I., "Environmental toxicity, redox signaling and lung
inflammation: the role of glutathione." Mol Aspects Med, 30 (1-2), 2009, 60-76.
[47] Yuan, L.; Kaplowitz, N., "Glutathione in liver diseases and hepatotoxicity." Mol
Aspects Med, 30 (1-2), 2009, 29-41.
[48] Schafer, F. Q.; Buettner, G. R., "Redox environment of the cell as viewed through
the redox state of the glutathione disulfide/glutathione couple." Free Radical Bio Med, 30 (11), 2001, 1191-1212.
[49] Jones, D. P., "Redox potential of GSH/GSSG couple: assay and biological
significance." Methods Enzymol, 348, 2002, 93-112.
[50] Adams, J. D.; Wang, B.; Klaidman, L. K.; Lebel, C. P.; Odunze, I. N.; Shah,
D., "New Aspects of Brain Oxidative Stress-Induced by Tert-Butylhydroperoxide."
Free Radical Bio Med, 15 (2), 1993, 195-202.
[51] Lovell, M. A.; Ehmann, W. D.; Butler, S. M.; Markesbery, W. R., "Elevated
thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain
in Alzheimer′s disease." Neurology, 45 (8), 1995, 1594-601.
[52] Sofic, E.; Lange, K. W.; Jellinger, K.; Riederer, P., "Reduced and oxidized
glutathione in the substantia nigra of patients with Parkinson′s disease." Neurosci
Lett, 142 (2), 1992, 128-30.
[53] Miller, V. M.; Lawrence, D. A.; Mondal, T. K.; Seegal, R. F., "Reduced
glutathione is highly expressed in white matter and neurons in the unperturbed
mouse brain--implications for oxidative stress associated with neurodegeneration."
Brain Res, 1276, 2009, 22-30.
[54] Lei, Y. L.; Huang, K.; Gao, C.; Lau, Q. C.; Pan, H.; Xie, K.; Li, J. Y.; Liu,
R.; Zhang, T.; Xie, N.; Nai, H. S.; Wu, H.; Dong, Q.; Zhao, X.; Nice, E. C.;
Huang, C. H.; Wei, Y. Q., "Proteomics Identification of ITGB3 as a Key Regulator
in Reactive Oxygen Species-induced Migration and Invasion of Colorectal Cancer
Cells." Mol Cell Proteomics, 10 (10), 2011.
[55] Patel, B. P.; Rawal, U. M.; Dave, T. K.; Rawal, R. M.; Shukla, S. N.; Shah, P.
M.; Patel, P. S., "Lipid peroxidation, total antioxidant status, and total thiol levels
predict overall survival in patients with oral squamous cell carcinoma." Integr
Cancer Ther, 6 (4), 2007, 365-372.
[56] Chaiswing, L.; Oberley, T. D., "Extracellular/microenvironmental redox state."
Antioxid Redox Signal, 13 (4), 2010, 449-65.
[57] Kuppusamy, P.; Li, H.; Ilangovan, G.; Cardounel, A. J.; Zweier, J. L.;
Yamada, K.; Krishna, M. C.; Mitchell, J. B., "Noninvasive imaging of tumor redox
status and its modification by tissue glutathione levels." Cancer Res, 62 (1), 2002,
307-12.
[58] Perry, R. R.; Mazetta, J. A.; Levin, M.; Barranco, S. C., "Glutathione levels and
variability in breast tumors and normal tissue." Cancer, 72 (3), 1993, 783-7.
[59] Russo, A.; DeGraff, W.; Friedman, N.; Mitchell, J. B., "Selective modulation of
glutathione levels in human normal versus tumor cells and subsequent differential
response to chemotherapy drugs." Cancer Res, 46 (6), 1986, 2845-8.
[60] Wu, C.; Gong, M. Q.; Liu, B. Y.; Zhuo, R. X.; Cheng, S. X., "Co-delivery of
multiple drug resistance inhibitors by polymer/inorganic hybrid nanoparticles to
effectively reverse cancer drug resistance." Colloid Surface B, 149, 2017, 250-259.
[61] Gamcsik, M. P.; Kasibhatla, M. S.; Teeter, S. D.; Colvin, O. M., "Glutathione
levels in human tumors." Biomarkers, 17 (8), 2012, 671-91.
[62] He, Q.; Chen, J.; Yan, J.; Cai, S.; Xiong, H.; Liu, Y.; Peng, D.; Mo, M.; Liu,
Z., "Tumor microenvironment responsive drug delivery systems." Asian J Pharm
Sci, 15 (4), 2020, 416-448.
[63] Guo, X. S.; Cheng, Y.; Zhao, X. T.; Luo, Y. L.; Chen, J. J.; Yuan, W. E.,
"Advances in redox-responsive drug delivery systems of tumor microenvironment."
J Nanobiotechnol, 16, 2018.
[64] Mollazadeh, S.; Mackiewicz, M.; Yazdimamaghani, M., "Recent advances in the
redox-responsive drug delivery nanoplatforms: A chemical structure and physical
property perspective." Mat Sci Eng C-Mater, 118, 2021, 11536.
[65] Wang, Z.; Ling, L. B.; Du, Y. W.; Yao, C.; Li, X. S., "Reduction responsive
liposomes based on paclitaxel-ss-lysophospholipid with high drug loading for
intracellular delivery." Int J Pharm, 564, 2019, 244-255.
[66] Chen, Y. F.; Hsu, M. W.; Su, Y. C.; Chang, H. M.; Chang, C. H.; Jan, J. S.,
"Naturally derived DNA nanogels as pH- and glutathione-triggered anticancer drug
carriers." Mat Sci Eng C-Mater, 114, 2020, 111025.
[67] Du, X.; Kleitz, F.; Li, X. Y.; Huang, H. W.; Zhang, X. J.; Qiao, S. Z.,
"Disulfide-Bridged Organosilica Frameworks: Designed, Synthesis, Redox-
Triggered Biodegradation, and Nanobiomedical Applications." Adv Funct Mater, 28
(26), 2018, 1707325.
[68] Cheng, Y.; Ji, Y. H., "Mitochondria-targeting nanomedicine self-assembled from
GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment
with enhanced cytotoxicity." J Control Release, 318, 2020, 38-49.
[69] Du, Y. W.; He, W.; Zhou, W. Y.; Li, X. S., "Disulfide phosphatidylcholines:
alternative phospholipids for the preparation of functional liposomes." Chem
Commun, 55 (58), 2019, 8434-8437.
[70] Nie, Y. Y.; Xu, Y. R.; Gao, Y.; He, J. L.; Sun, L.; Chen, J. M.; Cui, Y. S.; Ge,
H. X.; Ning, X. H., "A glutathione-triggered precision explosive system for
improving tumor chemosensitivity." Nano Res, 2020.
[71] Liu, D. C.; Chen, B. L.; Mo, Y. L.; Wang, Z. H.; Qi, T.; Zhang, Q.; Wang, Y.
G., "Redox-Activated Porphyrin-Based Liposome Remote-Loaded with
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy
through Induction of Immunogenic Cell Death and Blockage of IDO Pathway (vol
19, pg 6964, 2019)." Nano Lett, 20 (2), 2020, 1476-1476.
[72] Elzes, M. R.; Akeroyd, N.; Engbersen, J. F. J.; Paulusse, J. M. J., "Disulfide-
functional poly(amido amine)s with tunable degradability for gene delivery." J
Control Release, 244, 2016, 357-365.
[73] Li, S. L.; Saw, P. E.; Lin, C. H.; Nie, Y.; Tao, W.; Farokhzad, O. C.; Zhang,
L.; Xu, X. D., "Redox-responsive polyprodrug nanoparticles for targeted siRNA
delivery and synergistic liver cancer therapy." Biomaterials, 234, 2020, 119760.
[74] Wang, B.; Zhang, J.; Liu, Y. H.; Zhang, W.; Xiao, Y. P.; Zhao, R. M.; Yu, X.
Q., "A reduction-responsive liposomal nanocarrier with self-reporting ability for
efficient gene delivery." J Mater Chem B, 6 (18), 2018, 2860-2868.
[75] Lv, H. Y.; Ma, S.; Wang, Z. B.; Ji, X. T.; Lv, S. P.; Ding, C. F., "Glutathione-
triggered non-template synthesized porous carbon nanospheres serve as low toxicity
targeted delivery system for cancer multi-therapy." Chinese Chem Lett, 32 (5), 2021,
1765-1769.
[76] Baldwin, A. D.; Kiick, K. L., "Reversible maleimide-thiol adducts yield glutathione-
sensitive poly(ethylene glycol)-heparin hydrogels." Polym Chem-Uk, 4 (1), 2013,
133-143.
[77] Cheng, G.; He, Y. Y.; Xie, L.; Nie, Y.; He, B.; Zhang, Z. R.; Gu, Z. W.,
"Development of a reduction-sensitive diselenide-conjugated oligoethylenimine
nanoparticulate system as a gene carrier." Int J Nanomed, 7, 2012, 3991-4006.
[78] Liang, Y. K.; Kiick, K. L., "Liposome-Cross-Linked Hybrid Hydrogels for
Glutathione-Triggered Delivery of Multiple Cargo Molecules." Biomacromolecules,
17 (2), 2016, 601-614.
[79] Zhai, S.; Hu, X.; Hu, Y.; Wu, B.; Xing, D., "Visible light-induced crosslinking
and physiological stabilization of diselenide-rich nanoparticles for redox-responsive
drug release and combination chemotherapy." Biomaterials, 121, 2017, 41-54.
[80] Galdiero, S.; Falanga, A.; Cantisani, M.; Vitiello, M.; Morelli, G.; Galdiero,
M., "Peptide-lipid interactions: experiments and applications." Int J Mol Sci, 14 (9),
2013, 18758-89.
[81] Jiang, Y. J.; Chen, Y. Y.; Song, Z. Y.; Tan, Z. Z.; Cheng, J. J., "Recent advances
in design of antimicrobial peptides and polypeptides toward clinical translation."
Adv Drug Deliver Rev, 170, 2021, 261-280.
[82] McMillan, K. A. M.; Coombs, M. R. P., "Review: Examining the Natural Role of
Amphibian Antimicrobial Peptide Magainin." Molecules, 25 (22), 2020, 5436.
[83] Li, Q. Q.; Chen, P. G.; Hu, Z. W.; Cao, Y.; Chen, L. X.; Chen, Y. X.; Zhao,
Y. F.; Li, Y. M., "Selective inhibition of cancer cells by enzyme-induced gain of
function of phosphorylated melittin analogues." Chem Sci, 8 (11), 2017, 7675-7681.
[84] Jiang, Z. Q.; Vasil, A. I.; Hale, J. D.; Hancock, R. E. W.; Vasil, M. L.; Hodges, R. S., "Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides." Biopolymers, 90 (3), 2008, 369-383.
[85] Li, M. Y.; Wang, S. J.; Xu, J.; Xu, S. H.; Liu, H. L., "pH/Redox-Controlled
Interaction between Lipid Membranes and Peptide Derivatives with a "Helmet"." J
Phys Chem B, 123 (31), 2019, 6784-6791.
[86] Mizukami, S.; Hosoda, M.; Satake, T.; Okada, S.; Hori, Y.; Furuta, T.;
Kikuchi, K., "Photocontrolled Compound Release System Using Caged
Antimicrobial Peptide." Journal of the American Chemical Society, 132 (28), 2010,
9524-9525.
[87] Mizukami, S.; Kashibe, M.; Matsumoto, K.; Hori, Y.; Kikuchi, K., "Enzyme-
triggered compound release using functionalized antimicrobial peptide derivatives
(vol 8, pg 3047, 2017)." Chemical Science, 8 (4), 2017, 3276-3276.
[88] Huang, J. R.; Lee, M. H.; Li, W. S.; Wu, H. C., "Liposomal Irinotecan for
Treatment of Colorectal Cancer in a Preclinical Model." Cancers, 11 (3), 2019.
[89] Yang, J.; Bahreman, A.; Daudey, G.; Bussmann, J.; Olsthoorn, R. C. L.; Kros,
A., "Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified
Liposomes." Acs Central Sci, 2 (9), 2016, 621-630.
[90] Zalipsky, S.; Mullah, N.; Harding, J. A.; Gittelman, J.; Guo, L.; DeFrees, S. A.,
"Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide
ligands appended to the termini of the polymer chains." Bioconjugate Chem, 8 (2),
1997, 111-118.
[91] Versluis, F.; Voskuhl, J.; van Kolck, B.; Zope, H.; Bremmer, M.; Albregtse,
T.; Kros, A., "In Situ Modification of Plain Liposomes with Lipidated Coiled Coil
Forming Peptides Induces Membrane Fusion." Journal of the American Chemical
Society, 135 (21), 2013, 8057-8062.
[92] Marques-Gallego, P.; de Kroon, A. I. P. M., "Ligation Strategies for Targeting
Liposomal Nanocarriers." Biomed Res Int, 2014, 2014, 1-12.
[93] Lim, S. K.; Sanden, C.; Selegard, R.; Liedberg, B.; Aili, D., "Tuning Liposome
Membrane Permeability by Competitive Peptide Dimerization and Partitioning-
Folding Interactions Regulated by Proteolytic Activity." Sci Rep-Uk, 6, 2016.
[94] Cavalli, S.; Overhand, M.; Kros, A., "Assembly into beta-Sheet Structures upon
Peptide-Liposome Conjugation through Copper(I)-Catalyzed [3+2] Azide-Alkyne
Cycloaddition." Chempluschem, 79 (4), 2014, 564-568.
[95] Ringhieri, P.; Mannucci, S.; Conti, G.; Nicolato, E.; Fracasso, G.; Marzola, P.;
Morelli, G.; Accardo, A., "Liposomes derivatized with multimeric copies of
KCCYSL peptide as targeting agents for HER-2-overexpressing tumor cells." Int J
Nanomed, 12, 2017, 501-514.
[96] Tarallo, R.; Accardo, A.; Falanga, A.; Guarnieri, D.; Vitiello, G.; Netti, P.;
D′Errico, G.; Morelli, G.; Galdiero, S., "Clickable Functionalization of Liposomes
with the gH625 Peptide from Herpes simplex Virus Type I for Intracellular Drug
Delivery." Chem-Eur J, 17 (45), 2011, 12659-12668.
[97] Bak, M.; Jolck, R. I.; Eliasen, R.; Andresen, T. L., "Affinity Induced Surface Functionalization of Liposomes Using Cu-Free Click Chemistry." Bioconjugate Chem, 27 (7), 2016, 1673-1680.
[98] Bernhard, Y.; Gigot, E.; Goncalves, V.; Moreau, M.; Sok, N.; Richard, P.;
Decreau, R. A., "Direct subphthalocyanine conjugation to bombesin vs. indirect
conjugation to its lipidic nanocarrier." Org Biomol Chem, 14 (19), 2016, 4511-4518.
[99] Blenke, E. O.; Klaasse, G.; Merten, H.; Pluckthun, A.; Mastrobattista, E.,
"Liposome functionalization with copper-free "click chemistry"." J Control Release,
202, 2015, 14-20.
[100] Goto, C.; Hirano, M.; Hayashi, K.; Kikuchi, Y.; Hara-Kudo, Y.; Misawa,
T.; Demizu, Y., "Development of Amphipathic Antimicrobial Peptide Foldamers
Based on Magainin 2 Sequence." ChemMedChem, 14 (22), 2019, 1911-1916.
[101] Dai, Y. X.; Yue, N.; Liu, C. X.; Cai, X. G.; Su, X.; Bi, X. Z.; Li, Q. F.;
Li, C. Y.; Huang, W. L.; Qian, H., "Synthesis and evaluation of redox-sensitive
gonadotropin-releasing hormone receptor-targeting peptide conjugates." Bioorg
Chem, 88, 2019, 102945.
[102] Klein, P. M.; Reinhard, S.; Lee, D. J.; Muller, K.; Ponader, D.;
Hartmann, L.; Wagner, E., "Precise redox-sensitive cleavage sites for improved
bioactivity of siRNA lipopolyplexes." Nanoscale, 8 (42), 2016, 18098-18104.
[103] Goddard-Borger, E. D.; Stick, R. V., "An efficient, inexpensive, and shelf-stable
diazotransfer reagent: imidazole-1-sulfonyl azide hydrochloride." Org Lett, 9 (19),
2007, 3797-800.
[104] Marine, J. E.; Liang, X.; Song, S.; Rudick, J. G., "Azide-rich peptides via an
on-resin diazotransfer reaction." Biopolymers, 104 (4), 2015, 419-26.
[105] Hansen, M. B.; van Gurp, T. H. M.; van Hest, J. C. M.; Lowik, D. W. P. M.,
"Simple and Efficient Solid-Phase Preparation of Azido-peptides." Organic Letters,
14 (9), 2012, 2330-2333.
[106] Castro, V.; Banco-Canosa, J. B.; Rodriguez, H.; Albericio, F., "Imidazole-1-
sulfonyl Azide-Based Diazo-Transfer Reaction for the Preparation of Azido Solid
Supports for Solid-Phase Synthesis." Acs Comb Sci, 15 (7), 2013, 331-334.
[107] Hassane, F. S.; Frisch, B.; Schuber, F., "Targeted liposomes: Convenient
coupling of ligands to preformed vesicles using "click chemistry"." Bioconjugate
Chem, 17 (3), 2006, 849-854.
[108] Kumar, A.; Erasquin, U. J.; Qin, G. T.; Li, K.; Cai, C. Z., ""Clickable′′,
polymerized liposomes as a versatile and stable platform for rapid optimization of
their peripheral compositions." Chem Commun, 46 (31), 2010, 5746-5748.
[109] Smyth, T.; Petrova, K.; Payton, N. M.; Persaud, I.; Redzic, J. S.; Gruner,
M. W.; Smith-Jones, P.; Anchordoquy, T. J., "Surface Functionalization of
Exosomes Using Click Chemistry." Bioconjugate Chem, 25 (10), 2014, 1777-1784.
[110] Bianchini, E.; Pietrobon, L.; Ronchin, L.; Tortato, C.; Vavasori, A.,
"Trifluoroacetic acid promoted hydration of styrene catalyzed by sulfonic resins:
Comparison of the reactivity of styrene, n-hexene and cyclohexene." Appl Catal a-
Gen, 570, 2019, 130-138. |
[Endnote RIS 格式]
[相關文章]
[文章引用]
[完整記錄]
[館藏目錄]
[檢視]
plurk
funp
live
udn
HD
myshare
netvibes
friend
youpush
delicious
baidu
Google bookmarks
del.icio.us
hemidemi
facebook
twitter
google
reddit